Search
Request a Quote

Controls and Calibrators Development Service

Background

Controls and calibrators are essential to the reliability of in vitro diagnostic testing, but they serve different purposes. Calibrators establish the relationship between instrument response and analyte concentration or activity, while controls help laboratories monitor whether the assay continues to perform as expected. Both require carefully selected matrices, stable analytes, reproducible manufacturing, and value-assignment strategies appropriate to the intended method.

As part of our IVD reagent and kit contract manufacturing service, Creative Enzymes Diagnostic develops customized controls and calibrators from initial specification and matrix design through analyte preparation, value assignment, homogeneity evaluation, stability studies, filling, and pilot production. Programs can support new assay kits, replacement of existing materials, expanded concentration ranges, multi-analyte products, or adaptation to a specific instrument platform.

IVD controls and calibrators development from matrix design to value assignment

Controls and Calibrators: Distinct Functions, Coordinated Development

Although controls and calibrators may contain the same analyte, they cannot automatically be used interchangeably. Their target concentrations, assigned values, acceptance ranges, matrices, packaging, and instructions must reflect their intended function within the assay. We define these requirements at project initiation to avoid design choices that compromise calibration accuracy or quality-control monitoring.

Calibrators

  • Establish the response-to-concentration or response-to-activity relationship
  • Support single-point, two-point, or multi-point calibration models
  • Cover the measuring interval required by the assay
  • Require carefully assigned target values and stated units
  • May support lot-specific, master, or instrument-specific calibration approaches
  • Require stability compatible with the proposed calibration interval and use pattern

Control Materials

  • Monitor assay performance after calibration
  • Represent normal, borderline, pathological, positive, or negative levels
  • Challenge performance near clinically or analytically important decision points
  • Use target values with acceptable control ranges
  • May be single-analyte, multi-analyte, assay-specific, or platform-specific
  • Require consistent behavior over routine storage and repeated use

Materials and Formats We Develop

Development can begin with a required control or calibration profile, an existing product that needs replacement, or a diagnostic kit under development. The material format is selected according to the assay chemistry, analyte stability, laboratory workflow, intended shelf life, and manufacturing requirements.

Product Configurations

  • Single-analyte and multi-analyte materials
  • Positive, negative, and process controls
  • Normal, low, high, and clinically relevant challenge levels
  • Single-point and multi-level calibrator sets
  • Qualitative, semi-quantitative, and quantitative assay materials
  • Assay-kit controls and standalone quality-control products

Storage and Presentation Formats

  • Liquid-stable and ready-to-use materials
  • Frozen single-use or multi-use aliquots
  • Lyophilized controls and calibrators
  • Concentrated materials requiring dilution
  • Vials, bottles, ampoules, tubes, cartridges, and kit-integrated formats
  • Bulk, semi-finished, and finished labeled configurations

Intended-Use and Specification Definition

Development begins by translating the assay's operating needs into a material specification. We review the analyte, assay principle, instrument, calibration model, reportable range, clinical decision points, specimen matrix, user workflow, packaging, and desired shelf life. The result is a target profile that defines what the material must contain and how its performance will be assessed.

Concentration and Level Design

Control levels are selected to challenge the assay at meaningful positions rather than simply dividing the measuring interval into equal segments. Depending on the test, levels may represent the expected normal range, a medical decision point, a low-positive region, or a high-concentration condition. Calibrator levels are distributed to support the chosen mathematical model and must adequately define the assay response across the intended interval.

Acceptance Criteria and Use Conditions

The development specification may define:

Matrix Selection and Engineering

The matrix influences analyte recovery, reaction kinetics, binding, commutability, stability, microbial risk, and manufacturability. A matrix that stabilizes the analyte may still create bias relative to patient samples, while a highly native matrix may introduce supply, biosafety, or lot-variation challenges. We select and optimize the matrix according to the intended assay and the degree of clinical-sample similarity required.

Biological Matrices

  • Human serum, plasma, blood-derived, urine, or other specimen-related matrices
  • Animal-derived serum or plasma alternatives
  • Pooled or processed biological materials
  • Analyte-depleted or selectively modified matrices
  • Cell-, microorganism-, or tissue-associated materials where appropriate
  • Matrix screening for endogenous target and interferent levels

Synthetic and Hybrid Matrices

  • Buffer-based and protein-based synthetic materials
  • Recombinant or purified carrier components
  • Hybrid matrices combining biological and defined ingredients
  • Viscosity, ionic-strength, protein, and pH adjustment
  • Surfactants, preservatives, antioxidants, and protective excipients
  • Controlled background designed for a specific assay mechanism

Matrix Processing and Background Control

Matrix preparation may include filtration, delipidation, dialysis, heat treatment, target depletion, clarification, microbial-control steps, or adjustment of endogenous constituents. Processing conditions are selected carefully because they can alter protein structure, analyte binding, turbidity, viscosity, and assay response. After treatment, the matrix is reassessed in the target method before analyte concentration is finalized.

Analyte Sourcing and Concentration Adjustment

The analyte source can affect immunoreactivity, catalytic activity, molecular form, post-translational modification, stability, and method response. We evaluate native, recombinant, purified, synthetic, inactivated, or otherwise characterized materials according to the assay principle. For multi-analyte products, each component must remain stable and measurable without adversely affecting the others.

Analyte Qualification

  • Identity, purity, concentration, or activity
  • Relevant molecular form or isoform
  • Antigenicity, catalytic behavior, or amplification performance
  • Matrix recovery and dilution behavior
  • Stability during preparation, storage, and use
  • Lot consistency and long-term availability

Level Preparation

  • Direct spiking into the selected matrix
  • Dilution of a high-concentration stock
  • Blending of positive and negative matrix pools
  • Adjustment of enzyme activity or molecular copy level
  • Preparation of independent or serially related levels
  • Verification after equilibration, filling, and processing

Formulation and Stabilization Development

Controls and calibrators must retain their assigned behavior throughout preparation, filling, storage, shipment, and use. Stabilization is optimized for the complete material rather than for the analyte alone. Buffer composition, protein content, preservatives, surfactants, antioxidants, chelators, sugars, polyols, and other excipients are screened for their effects on analyte recovery, matrix properties, assay response, and long-term consistency.

For lyophilized products, formulation work also addresses freezing stress, drying recovery, cake appearance, residual moisture, reconstitution time, and post-reconstitution stability. For liquid products, attention is given to adsorption, precipitation, microbial control, evaporation, and repeated opening. Container and closure materials are evaluated because surface interactions or moisture exchange can change the apparent analyte value over time.

Value Assignment and Traceability Strategy

Value assignment converts a prepared material into a usable calibrator or control. The strategy depends on the measurand, available reference systems, intended method, number of instruments and reagent lots, and whether the material is intended for calibration or quality control. Where suitable reference measurement procedures or certified reference materials are available, they can be incorporated into the traceability plan. When no higher-order reference exists, values may be assigned through a defined comparative or consensus procedure.

Value-Assignment Study Design

Control Ranges and Reassignment

For control materials, the expected range must be broad enough to accommodate normal analytical variation but narrow enough to detect a meaningful shift. Ranges may be established for a specific assay, reagent lot, instrument family, or broader method group. We can also support reassignment after a formulation, matrix, instrument, or reagent change when the previous values are no longer directly applicable.

Commutability and Method Compatibility

Commutability describes whether a reference material behaves like representative patient samples across different measurement procedures. It cannot be assumed from matrix type alone. Processing, analyte source, concentration adjustment, preservatives, and stabilization can all create method-dependent behavior. The required level of evaluation depends on the product's intended use and whether it will be used across one or multiple methods.

A comparative study can include patient samples spanning the relevant range together with the candidate control or calibrator. Relationships among methods are assessed to determine whether the material follows the same pattern as the clinical specimens. If a matrix-related bias is identified, we may adjust the matrix or analyte source, narrow the intended platform claim, or assign method-specific values rather than treating the material as universally interchangeable.

Homogeneity and Stability Evaluation

Homogeneity testing determines whether units from the same lot can be used interchangeably. Stability testing evaluates whether the assigned behavior is maintained over the proposed storage and use period. Both studies require a representative sampling plan, an analytical method with adequate precision, predefined acceptance criteria, and control of the testing sequence.

Homogeneity Studies

  • Bulk mixing and fill-sequence assessment
  • Within-vial or within-unit variation
  • Between-vial or between-unit variation
  • Beginning, middle, and end-of-fill sampling
  • Multi-analyte uniformity
  • Functional testing using the intended assay

Stability Studies

  • Accelerated and real-time stability
  • Transport and temperature-excursion stability
  • Open-vial and repeated-use stability
  • Onboard stability where applicable
  • Freeze–thaw stability
  • Reconstituted stability for lyophilized materials

Pilot Manufacturing and Quality Control

Scale-up introduces risks that may not be visible during bench preparation. We define the order of addition, mixing time, temperature, equilibration, filtration, hold time, filling sequence, closure, and storage conditions needed to preserve material uniformity. Pilot batches are used to examine process yield, fill consistency, analyte recovery, and the effect of lyophilization or other processing steps.

Release testing is tailored to the product and may include appearance, reconstitution, pH, osmolality, protein concentration, analyte value, enzyme activity, qualitative status, vial-to-vial consistency, microbial or safety-related attributes, and performance in the intended assay. Batch records, material specifications, in-process controls, and acceptance criteria are prepared to support reproducible manufacture.

Development Workflow

Controls and calibrators development service workflow

Deliverables

The final documentation package is aligned with the product type and development scope. Typical deliverables include:

Item Description
Product Target Profile Definition of intended use, material type, analyte levels, matrix, assay platform, packaging, storage, stability, and performance requirements.
Matrix and Analyte Selection Report Evaluation of candidate matrices and analyte sources, including background, recovery, functional response, processing requirements, and selection rationale.
Optimized Control or Calibrator Formulation Recommended matrix composition, analyte concentration, stabilizers, preservatives, preparation sequence, and critical storage or handling conditions.
Prototype or Pilot Materials Development-stage control or calibrator units prepared at the agreed levels and in the selected liquid, frozen, lyophilized, or kit-integrated format.
Value Assignment and Traceability Report Assigned values or ranges, study design, analytical procedures, statistical summary, units, traceability statement, and identified limitations.
Homogeneity and Compatibility Data Within-unit and between-unit results together with available method-comparison, matrix-effect, or commutability-related findings.
Stability Data and Study Plan Available accelerated, real-time, transport, open-vial, freeze–thaw, or reconstituted stability results and recommendations for continued monitoring.
Manufacturing and QC Documentation Draft production instructions, filling requirements, in-process controls, release tests, acceptance criteria, packaging recommendations, and scale-up considerations.

FAQs

Creative Enzymes Diagnostic combines assay-development experience, diagnostic raw material expertise, matrix engineering, analytical characterization, and scalable manufacturing support to create dependable controls and calibrators. Each program is designed around the material's intended function so that concentration levels, assigned values, stability, and production controls work together as a coherent product.

Contact our business development team today to discuss your custom control or calibrator development needs!

Related Services

Online Inquiry

For research and industrial use only, not for personal medicinal use.

Submit